Skip to content

A randomized controlled study of the safety, efficacy, and complications of percutaneous renal artery balloon occlusion combined with laparoscopic or robotic partial nephrectomy

A randomized controlled study of the safety, efficacy of percutaneous renal artery balloon occlusion combined with laparoscopic or robotic partial nephrectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075035
Enrollment
Unknown
Registered
2023-08-23
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal tumour

Interventions

Sponsors

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Renal tumors with clinical stage T1; 2) Renal tumors with a high risk of renal arterial and venous separation (history of surgery, solitary kidney, complex variant branches, etc.); (3) Imaging shows a single arterial feed to the renal tumor; 4) renal tumors for which partial nephrectomy via the abdominal route is proposed;

Exclusion criteria

Exclusion criteria: 1 ) Patients with severe underlying diseases of the heart, lungs, liver, kidneys, and blood; 2 ) Patients with severe underlying diseases of the great vessels such as aneurysms; 3 ) Patients who refuse to join the study; 4 ) Patients who cannot accept standardized treatment and cannot cooperate with follow-up visits; 5) Patients who are younger than 18 years old, or older than 70 years old;

Design outcomes

Primary

MeasureTime frame
postoperative complication;

Secondary

MeasureTime frame
Preoperative renal function;Postoperative renal function;Estimation of blood loss;Blocking time;Operation time;recurrence and metastasis;

Countries

China

Contacts

Public ContactLi Heng

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology

lihengtjmu@163.com+86 189 8629 2538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026